Norovirus

>

Latest News

Vaxart’s Oral Norovirus Vaccine Shows Stronger Mucosal Response
Vaxart’s Oral Norovirus Vaccine Shows Stronger Mucosal Response

September 11th 2025

Head-to-head phase 1 data indicate larger fecal IgA responses after a single tablet vs first-generation constructs, with plans to advance to mid-stage testing.

FDA Clears Human Challenge Trial for First Potential Norovirus Antiviral, CDI-988
FDA Clears Human Challenge Trial for First Potential Norovirus Antiviral, CDI-988

September 9th 2025

Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine
Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine

March 6th 2025

Enhancing Air Quality and Controlling Infections on Cruise Ships
Enhancing Air Quality and Controlling Infections on Cruise Ships

February 3rd 2025

Human Milk Sugar Blocks Norovirus in Lab Models
Human Milk Sugar Blocks Norovirus in Lab Models

January 23rd 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.